InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | 2026-05-06 | Vairavan Latha | SVP Chief Financial Officer | Sale | 1,341 | $23.61 | $32K | 86.4K | View ↗ | |
| 2026-05-04 | 2026-05-06 | Watanabe Todd | Director & See Remarks | Sale | 3,172 | $23.61 | $75K | 720.8K | View ↗ | |
| 2026-05-04 | 2026-05-06 | Burnett Patrick | See Remarks | Sale | 684 | $23.61 | $16K | 120.5K | View ↗ | |
| 2026-05-04 | 2026-05-06 | Matsuda Masaru | See Remarks | Sale | 8,256 | $23.31 | $192K | 126.7K | View ↗ | |
| 2026-03-02 | 2026-03-03 | Watanabe Todd | Director & See Remarks | Sale | 37.3K | $25.18 | $941K | 786.0K | View ↗ |
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2025-12-11 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2023-09-15 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2023-04-17 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2022-06-15 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
No annual data found.
Arcutis Biotherapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Arcutis outlines $480M-$495M 2026 revenue guidance while expanding ZORYVE sales teams
Arcutis Biotherapeutics, Inc. (ARQT) Q1 2026 Earnings Call Transcript
Arcutis Biotherapeutics Q1 Earnings Call Highlights